|
DRCR Retina Network
|
Research Initiative
|
OS
|
NEI, NIDDK
|
The DRCR Retina Network (formerly known as the Diabetic Retinopathy Clinical Research Network) (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema, and associated conditions. The DRCR.net supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. The network is funded by the National Eye Institute (NEI), and co-funded by the Office of the Secretary (OS), through National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with the Special Funding Program for Type 1 Diabetes Research.
|
|
Drug Development Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
ASPR
|
NCI, NHLBI, NIAID
|
DDIG is a NIAID team that promotes knowledge sharing and discussions on drug development, technological platforms and models for the discovery and development of antiinfectives having different chemical structures and modalities (e.g. small molecule-, peptide-, natural product-based inhibitors, antibodies, targeted degradation, live microbes). The team aims to identify gaps and opportunities to advance translational and clinical research for treatment of bacterial, viral, fungal and parasitic infections, particularly those cause by antibiotic resistant pathogens and viruses of pandemic potential
|
|
Drug Induced Liver Injury Network
|
Resource Development
|
FDA
|
NCI, NIDDK
|
Both a prospective and retrospective database containing cases of drug-induced liver disease, the Drug-Induced Liver Injury Network (DILIN) is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. Established by NIDDK, one of the goals of the DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. The DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Employees of the Food and Drug Administration (FDA) serve as ad hoc members on the committee overseeing the network activities.
|
|
Early Hearing Detection and Intervention Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NIDCD
|
This collaboration focuses on a teleconference sponsored by CDC.
|
|
ECHO Institute and Project ECHO for Cancer Research and Control
|
Other
|
CDC
|
NCI
|
The mission of Project ECHO (Extension for Community Healthcare Outcomes) at the University of New Mexico Health Sciences Center (UNMHSC) is to demonopolize knowledge and amplify the capacity to provide best practice care for underserved people all over the world. In pursuit of this mission, Project ECHO® faculty, staff and partners have dedicated themselves to de-monopolizing knowledge in order to expand access to best-practice medical care across the United States and globally. The ECHO model utilizes a technology-enabled case-based knowledge exchange approach. The NCI/CGH through partnership with the ECHO Institute utilizes the ECHO model to convene global cancer research and control networks to exchange knowledge to advance the uptake of evidence-based interventions to advance cancer control and build research partnerships. Project Extension for Community Healthcare Outcomes (ECHO) is a collaborative medical education model that aims to build workforce and knowledge capacity, through use of online videoconferencing to allow for knowledge exchange across interdisciplinary teams on relevant medical, healthcare, and health systems related topics. The National Cancer Institute (NCI) Center for Global Health (CGH) Project Echo Cancer Control Planning Program will link participants active in cancer control planning in low- and middle-income country settings with researchers, regional colleagues, and relevant technical experts, through monthly ECHO sessions that will provide virtual didactic instruction, case study learning, and knowledge exchange on relevant evidence-based cancer control planning principles. These sessions will relay evidence-based, general cancer control principals and related to cervical cancer screening. The CGH Project ECHO program’s primary goals are to increase participant knowledge of the aforementioned topics, improve the application of knowledge, including evidence-based practices and policies, and to increase collaboration among participants and experts who are active in cancer control planning in the participating countries.
|
|
Emergency Preparedness, Medical Countermeasures
|
Other
|
ASPR, CDC
|
NCI
|
NCI provides expertise in radiation biology, radiation oncology and disaster preparedness and response to ASPR for radiological and nuclear incidents. Collaboration Type: Subject matter expertise
|
|
Enabling Discovery through GEnomics (EDGE)
|
Research Initiative
|
Not Reported
|
NHGRI, NIAID
|
To advance understanding of comparative and functional genomics
|
|
End-Stage Renal Disease Collaboration
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA
|
NIBIB, NIDDK
|
Participating agencies, including NIDDK, and patient and physician groups are collaborating to help the medical product development community to understand the challenges and milestones needed to achieve the goal of a successful alternative to dialysis. Research, regulatory, and reimbursement needs for such a product are discussed in phone calls and structured meetings.
|
|
Ending the HIV Epidemic in the U.S. (EHE) Operational Leadership Principals Team
|
Committee, Work group, Advisory group, or Task Force
|
OS/OASH/OIDP, CDC, HRSA (HAB), HRSA (BPHC), IHS, SAMHSA
|
NIAID, NIMH, OD/DPCPSI/OAR
|
This committee now meets monthly with senior leadership from different agencies for critical thinking and in-depth discussions on EHE progress, and opportunities to optimize coordination for optimal EHE program outcomes.
|
|
Ending the HIV Epidemic in the US administrative supplement announcement for NIH Centers for AIDS Research and NIMH AIDS Research Centers
|
Research Initiative
|
CDC, HRSA
|
NIAID, NIMH, OD/DPCPSI/OAR
|
The NIH CFAR and NIMH ARC EHE administrative supplements support implementation research by addressing the four key pillars of the EHE initiative (Diagnose, Treat, Prevent, and Respond). Specifically, the NIH will support CFAR/ARC investigators to conduct research in collaboration with local partners funded by the participating HHS agencies to support local EHE plans. CDC and HRSA provided key support in the development of the research topics.
|